UnitedHealth Group Incorporated

Company Overview

Business Model: UnitedHealth Group Incorporated is a health care and well-being company with a mission to help people live healthier lives and make the health system work better for everyone. It operates through two distinct, yet complementary businesses: Optum and UnitedHealthcare. Optum is an information and technology-enabled health services business that integrates clinical expertise, technology, and data to create a more effective and affordable health care experience. UnitedHealthcare offers a comprehensive range of health benefits, aiming to simplify the health care experience and control costs for consumers.

Market Position: UnitedHealth Group Incorporated operates in highly competitive markets across the full spectrum of health care benefits and services. Its market position is underpinned by strong local-market relationships, a broad array of product offerings, advanced technology and service capabilities (including digital consumer engagement), competitive medical and operating cost structures, effective clinical engagement, and continuous innovation. The Company is a significant participant in the United States health markets, which constituted 19% of the gross domestic product in 2025.

Recent Strategic Developments:

• 2026 Business Realignment: Effective January 1, 2026, Optum Financial, including Optum Bank, will be realigned from Optum Health to Optum Insight. Prior period segment financial information will be recast to reflect this change.
• Net Portfolio Divestitures: In the fourth quarter of 2025, UnitedHealth Group Incorporated recorded a net gain of $568 million from business exits and dispositions, including a $1.5 billion gain at Optum Rx, partially offset by losses of $821 million at Optum Health and $68 million at Optum Insight. This includes an agreement to sell its remaining South American operations, expected to close in the second half of 2026.
• Restructuring and Other Actions: In the fourth quarter of 2025, UnitedHealth Group Incorporated incurred a total impact of $2.5 billion from restructuring and other actions. This included $746 million for real estate rationalization and workforce reductions, $573 million for contractual reassessments, $623 million for a loss contract reserve related to anticipated future losses in 2026 for certain value-based care businesses, $329 million in net valuation losses on equity securities, and $250 million for advance funding of the United Health Foundation.
• Cyberattack Response Costs: In the fourth quarter of 2025, UnitedHealth Group Incorporated increased its reserves by $799 million for net collection expectations associated with provider loans and other customer balances, following the Change Healthcare cyberattack in February 2024.

Geographic Footprint: UnitedHealth Group Incorporated primarily operates in the United States health markets. UnitedHealthcare Community & State participates in programs in 32 states and the District of Columbia. Certain businesses also operate internationally, though the Company is in the process of divesting its remaining South American operations.

Financial Performance

Revenue Analysis

(1) Gross Profit is calculated as Total Revenue less Medical Costs and Cost of Products Sold.

Profitability Metrics (2025):

• Gross Margin: 18.5%
• Operating Margin: 4.2%
• Net Margin: 2.7%

Investment in Growth (2025):

• Capital Expenditures: $3.6 billion (Purchases of property, equipment and capitalized software)
• Strategic Investments: $4.5 billion (Cash paid for acquisitions and other transactions)

Business Segment Analysis

UnitedHealthcare

Financial Performance:

• Revenue: $344.9 billion (+15.7% YoY)
• Operating Margin: 2.7% (down from 5.2% in 2024)
• Key Growth Drivers: Revenue growth was primarily driven by the Inflation Reduction Act (IRA)-driven impacts on Medicare Part D plans, growth in Medicare Advantage, and fee-based commercial offerings. Increased acuity needs within Medicaid also contributed.
• Operational Impact: Earnings from operations decreased due to Medicare Advantage funding reductions, elevated medical cost trends, impacts of market morbidity changes on individual exchange offerings, other write-offs and settlements, and restructuring and other actions. This was partially offset by decreased incremental medical costs for accommodations to support care providers in 2024 as a result of the Change Healthcare cyberattack.

Product Portfolio:

• UnitedHealthcare Employer & Individual: Offers comprehensive health benefit plans and services for large national, public sector, mid-sized, small employers, and individuals. Products include risk-based and fee-based (administrative services) offerings, consumer engagement products, traditional products, clinical and pharmacy products, and specialty benefits (vision, dental, accident protection, critical illness, disability, hospital indemnity).
• UnitedHealthcare Medicare & Retirement: Provides health and well-being services to seniors and other Medicare eligible consumers, including Medicare Advantage (HMO, PPO, Point-of-Service, Private-Fee-for-Service, Special Needs Plans), Medicare Part D (stand-alone and integrated), and Medicare Supplement products. The HouseCalls program performed 3.1 million clinical preventive home care visits in 2025.
• UnitedHealthcare Community & State: Serves state programs for economically disadvantaged, medically underserved, and those without employer-funded health care coverage, including Medicaid plans (Temporary Assistance to Needy Families, Children’s Health Insurance Programs, Dual SNPs, Long-Term Services and Supports, Aged, Blind and Disabled) and other federal, state, and community health care programs.

Market Dynamics:

• People Served (Medical): 49.76 million (+1% YoY)
  • Commercial: 29.65 million (flat YoY)
    • Risk-based: 8.165 million (-8% YoY)
    • Fee-based: 21.485 million (+3% YoY)
  • Medicare Advantage: 8.445 million (+8% YoY)
  • Medicaid: 7.38 million (-1% YoY)
  • Medicare Supplement: 4.285 million (-1% YoY)
• Medicare Part D stand-alone: 2.77 million (-9% YoY)
• Geographic Presence: UnitedHealthcare Community & State operates in 32 states and the District of Columbia.

Optum Health

Financial Performance:

• Revenue: $102.0 billion (-3.2% YoY)
• Operating Margin: -0.3% (down from 7.4% in 2024)
• Key Growth Drivers: Revenue decrease was primarily due to the conversion of risk-based contracts to fee-based arrangements, Medicare Advantage funding reductions, and changes in the member profile served. This was partially offset by growth in patients served under value-based arrangements.
• Operational Impact: Earnings from operations decreased due to Medicare Advantage funding reductions, elevated medical cost trends, the member profile of newly added patients under value-based care arrangements, and restructuring and other actions (including a $623 million loss contract reserve for anticipated future losses in 2026 for certain value-based care businesses). Gains on dispositions in 2024, impacts of net portfolio divestitures in 2025, and reduced investment income also contributed to the decrease. This was partially offset by cost management initiatives and decreased incremental medical costs for accommodations to support care providers in 2024 as a result of the Change Healthcare cyberattack.

Product Portfolio:

• Delivers patient-centered care, care management, wellness, consumer engagement, and health financial services.
• Provides primary, specialty, and surgical care; assists patients and providers with complex, chronic, and behavioral health needs; offers post-acute care planning services; and utilizes advanced digital health technologies (telehealth, remote patient monitoring).
• Offers fully accountable value-based arrangements, administrative fee arrangements, and fee-for-service arrangements.
• Optum Financial (moving to Optum Insight in 2026): Serves nearly 26 million consumer accounts with over $27 billion in assets under management as of December 31, 2025.

Market Dynamics:

• People Served: 95 million (down from 100 million in 2024)
• Customer Types: Works directly with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities.

Optum Insight

Financial Performance:

• Revenue: $19.4 billion (+3.5% YoY)
• Operating Margin: 13.5% (down from 16.5% in 2024)
• Key Growth Drivers: Revenue increased due to decreased impacts related to the Change Healthcare cyberattack and growth in technology services, partially offset by lower volumes within business services.
• Operational Impact: Earnings from operations decreased due to gains related to business portfolio refinement in 2024, lower volumes within business services, and the impacts of restructuring and other actions. This was partially offset by decreased impacts related to the Change Healthcare cyberattack.

Product Portfolio:

• Connects the health care system with services, analytics, and platforms to enhance clinical, administrative, and financial processes.
• Solutions include population health management, patient engagement, revenue cycle management, strategic growth plans, proactive analytics, payment integrity, risk and quality services, and modernization of core operating systems.

Market Dynamics:

• Customers: Serves hospital systems, physicians, health plans, public entities, and life sciences companies.
• Order Backlog: Approximately $31.1 billion as of December 31, 2025, with $18.3 billion expected to be realized within the next 12 months. This includes $12.9 billion related to affiliated agreements.

Optum Rx

Financial Performance:

• Revenue: $154.7 billion (+16.1% YoY)
• Operating Margin: 4.6% (up from 4.4% in 2024)
• Key Growth Drivers: Revenue increased due to higher script volumes from both new and existing clients and growth in pharmacy services.
• Operational Impact: Earnings from operations increased due to the impacts of net portfolio divestitures, including a $1.5 billion gain recognized on the deconsolidation of a business, and the factors impacting revenue. This was partially offset by restructuring and other actions and decreased investment income.

Product Portfolio:

• Provides a full spectrum of pharmacy care services, including retail network contracting, home delivery, specialty and community health pharmacies, infusion services, purchasing, and clinical capabilities.
• Develops programs in areas such as step therapy, formulary management, drug adherence, and disease and drug therapy management.
• Offers direct-to-consumer solutions and manages a broad range of prescription drug spending, including specialty pharmaceuticals.

Market Dynamics:

• Adjusted Scripts Fulfilled: 1,659 million (+2.2% YoY)
• Pharmaceutical Spending Managed: $188 billion in 2025, including nearly $87 billion in specialty pharmaceutical spending.
• Network: Operates through a network of approximately 64,000 retail pharmacies.
• Customers: Serves health benefits providers, large national employer plans, unions and trusts, purchasing coalitions, and public-sector entities.

Capital Allocation Strategy

Shareholder Returns (2025):

• Share Repurchases: $5.5 billion (12 million shares)
• Dividend Payments: $7.9 billion (annual rate increased to $8.84 per share in June 2025)
• Future Capital Return Commitments: As of December 31, 2025, 21 million shares remained authorized for repurchase under the Board of Directors’ program.

Balance Sheet Position (as of December 31, 2025):

• Cash and Equivalents: $24.4 billion
• Total Debt: $78.4 billion (Short-term borrowings: $6.1 billion; Long-term debt: $72.3 billion)
• Net Cash Position: -$54.0 billion (Net Debt)
• Credit Rating:
  • Moody’s: A2 (Negative Outlook)
  • S&P Global: A+ (Negative Outlook)
  • Fitch: A (Negative Outlook)
  • A.M. Best: A- (Stable Outlook)
• Debt Maturity Profile:
  • 2026: $6.1 billion
  • 2027: $3.5 billion
  • 2028: $3.6 billion
  • 2029: $3.7 billion
  • 2030: $3.9 billion
  • Thereafter: $58.7 billion

Cash Flow Generation (2025):

• Operating Cash Flow: $19.7 billion
• Free Cash Flow: $16.1 billion (Operating Cash Flow less Capital Expenditures)

Operational Excellence

Production & Service Model: UnitedHealth Group Incorporated's operational model is centered on building a modern, high-performing health system through improved access, affordability, outcomes, and experiences. This involves leveraging clinical expertise, technology, and data to advance whole-person health, create seamless consumer experiences, and support clinicians with insights for personalized, evidence-based care. The Company is focused on accelerating the transition to value-based care models and integrating in-clinic, in-home, behavioral, and virtual care.

Supply Chain Architecture: Key Suppliers & Partners:

• Pharmacy Network: Optum Rx operates through a network of approximately 64,000 retail pharmacies, home delivery, specialty, and community health pharmacies.
• Care Providers: UnitedHealthcare maintains extensive networks of physicians, hospitals, and other health care providers. Optum Health collaborates directly with care delivery systems and providers.
• Technology Partners: Optum Insight's products are supported and distributed through alliances and business partnerships with other technology vendors.

Facility Network:

• Executive Offices: Located at 1 Health Drive, Eden Prairie, Minnesota 55344 and 655 New York Avenue, Washington, DC 20001.
• Operational Facilities: UnitedHealth Group Incorporated owns and leases real properties in the United States and other countries to support its business operations.

Operational Metrics:

• Total Employees: More than 390,000 as of December 31, 2025.
• Clinical Professionals: Nearly 165,000 clinical professionals as of December 31, 2025.
• Optum Bank Consumer Accounts: Nearly 26 million consumer accounts with over $27 billion in assets under management as of December 31, 2025.
• HouseCalls Program: Nurse practitioners performed 3.1 million clinical preventive home care visits in 2025.

Market Access & Customer Relationships

Go-to-Market Strategy: Distribution Channels:

• Direct Sales: Utilized by Optum Health, Optum Insight, and Optum Rx. UnitedHealthcare Employer & Individual also employs direct sales.
• Channel Partners: Includes health insurance brokers and consultants (for Optum Rx and UnitedHealthcare Employer & Individual), external producers (for Optum Health), wholesale agents/agencies, professional employer organizations and associations, and multi-carrier and proprietary private exchange marketplaces (for UnitedHealthcare Employer & Individual). Optum Insight also leverages alliances and business partnerships with technology vendors.
• Digital Platforms: UnitedHealthcare emphasizes digital consumer engagement. Optum Health uses advanced, on-demand digital health technologies. Optum Rx offers direct-to-consumer solutions and digital tools.

Customer Portfolio: Enterprise Customers:

• Payers: Optum serves various payers, including health plans, third-party administrators, and underwriter/stop-loss carriers. UnitedHealthcare serves employers, seniors, and state programs.
• Care Providers: Optum serves physicians, hospitals, pharmacies, and other care providers.
• Employers: Optum Health and UnitedHealthcare Employer & Individual serve a range of employers from small businesses to large national entities.
• Governments: Optum serves federal, state, and municipal agencies. UnitedHealthcare Medicare & Retirement and Community & State serve government health care programs.
• Life Sciences Companies: Optum Insight serves pharmaceutical and medical technology companies. Customer Concentration: Premium revenues from Centers for Medicare & Medicaid Services (CMS) represented 44% of UnitedHealth Group Incorporated’s total consolidated revenues for the year ended December 31, 2025, primarily generated by UnitedHealthcare Medicare & Retirement.

Geographic Revenue Distribution:

• United States: The primary market for UnitedHealth Group Incorporated.
• International Exposure: Certain businesses operate internationally, though the Company is in the process of divesting its remaining South American operations.

Competitive Intelligence

Market Structure & Dynamics

Industry Characteristics: The U.S. health care market is characterized by consistent growth, reaching 19% of GDP in 2025. Key drivers include inflation, advancements in medical technology and pharmaceuticals, regulatory requirements, demographic shifts, and a national focus on health and well-being. The industry is evolving with a growing emphasis on value-based care models and integrated health management services.

Competitive Positioning Matrix:

Direct Competitors

Primary Competitors: UnitedHealth Group Incorporated operates in highly competitive markets across all its business segments. Competitors include a wide range of organizations, from startups to large global enterprises, encompassing for-profit and non-profit entities, as well as private and government-sponsored organizations. The filing does not name specific direct competitors.

Emerging Competitive Threats: New market entrants, business combinations among competitors and suppliers, and disruptive technologies or alternative solutions that could impact existing relationships with health plan enrollees.

Competitive Response Strategy: UnitedHealth Group Incorporated's strategy involves continuous product and service innovation, leveraging technology, enhancing consumer and provider engagement and satisfaction, and optimizing sales, marketing, and pricing strategies. A key focus is accelerating the transition to value-based care models and developing innovative care delivery approaches, including virtual and in-home care.

Risk Assessment Framework

Strategic & Market Risks

Market Dynamics:

• Medical Cost Management: Failure to accurately estimate, price for, and manage medical costs (e.g., medical cost inflation, increased service utilization, drug price increases, new treatments, regulatory changes) could materially and adversely affect the profitability of risk-based products and value-based arrangements.
• Competition: Intense competition from diverse entities, including new entrants and consolidated competitors, could impact market share, customer retention, and profitability. Failure to innovate or deliver valuable products/services could lead to loss of market share.
• Economic Conditions: Unfavorable economic conditions could reduce demand for products/services, impact the ability to increase premiums, lead to reduced government reimbursements (Medicare, Medicaid, CHIP), or adversely affect the financial position of care providers.
• Public Health Crises: Large-scale medical emergencies, pandemics, natural disasters, or the effects of climate change could disrupt business operations, increase costs, reduce demand, and impact workforce capacity.

Technology Disruption:

• Information Systems Integrity: Failure to maintain the integrity or availability of data, or to successfully consolidate, integrate, upgrade, or expand information systems, could lead to operational failures, customer loss, pricing issues, fraud control difficulties, regulatory sanctions, and increased expenses.
• AI Technologies: Increasing reliance on AI (including generative AI) presents risks if systems do not operate as intended, produce inaccurate or biased outputs, or if evolving laws and regulations impose new compliance requirements or limit AI uses.
• Cybersecurity Incidents: Cyberattacks or other privacy/data security incidents (e.g., the Change Healthcare cyberattack in 2024) could result in operational disruptions, data misappropriation or disclosure, revenue loss, increased costs, significant liability, and reputational harm.

Customer Concentration:

• CMS Revenue Concentration: Premium revenues from CMS represented 44% of UnitedHealth Group Incorporated’s total consolidated revenues in 2025, exposing the Company to risks associated with government program funding, enrollments, payment adjustments, audits, and investigations.

Operational & Execution Risks

Supply Chain Vulnerabilities:

• Provider Relationships: Failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals, pharmaceutical benefit service providers, and manufacturers at competitive prices could adversely affect business. Disputes or providers refusing to contract could lead to higher medical costs or less desirable products.
• Risk-Based Provider Arrangements: Exposure to risk related to the adequacy of financial and medical care resources of health care providers in risk-based arrangements; potential responsibility for unpaid claims if providers face financial difficulties.
• Pharmacy Care Services: Regulatory and operational risks unique to pharmacy care services, including anti-kickback laws, rebate regulations, formulary management, and potential claims for dispensing or operational errors.

Capacity Constraints:

• Talent Management: Failure to attract, develop, retain, and manage the succession of key employees and executives could adversely affect business, results of operations, and future performance, especially given high demand for skilled professionals in the health care and technology industries.

Financial & Regulatory Risks

Market & Financial Risks:

• Investment Portfolio Losses: Market fluctuations (e.g., interest rates, issuer defaults) could impair the value of investment and loan portfolios, adversely affecting profitability and equity.
• Intangible Asset Impairment: Material impairment of goodwill and other intangible assets ($131 billion carrying value as of December 31, 2025) could adversely affect results of operations, equity, and credit ratings.
• Credit Ratings: Any downgrades in credit ratings could materially increase borrowing and operating costs.

Regulatory & Compliance Risks:

• Extensive Regulation: Highly regulated business activities (U.S. federal and state, and international laws and regulations) mean new laws, changes in existing laws, or their enforcement could materially and adversely affect business operations.
• Government Program Participation: Participation in government health care programs (Medicare Advantage, Medicare Part D, Medicaid, CHIP) exposes the Company to risks from funding changes, enrollment shifts, payment adjustments, audits (e.g., RADV audits), and government investigations (e.g., False Claims Act lawsuit).
• Privacy & Security Regulations: Failure to comply with evolving privacy, security, technology, and data laws and regulations (HIPAA, HITECH, GLBA, state laws, international frameworks) could lead to increased operating costs, business model alterations, reputational harm, fines, penalties, and litigation.
• Corporate Practice of Medicine/Fee-Splitting: Laws in some states prohibiting specific entities from practicing medicine or employing physicians, or engaging in fee-splitting, could impact transaction structuring and physician relationships.
• Banking Regulation: Optum Bank is subject to supervision and regulation by the Utah State Department of Financial Institutions, the Federal Deposit Insurance Corporation (FDIC), and the Consumer Financial Protection Bureau, with potential for civil litigation, increased operational expenses, and sanctions from unfavorable examination results.
• Regulatory Capital Restrictions: Restrictions on the ability to obtain funds from regulated subsidiaries (due to minimum statutory capital requirements and dividend restrictions) could adversely affect the ability to reinvest in the business, service debt, and return capital to shareholders.

Geopolitical & External Risks

Geopolitical Exposure:

• Non-U.S. Regulation: International operations increase exposure to diverse non-U.S. regulatory regimes (e.g., taxation, licensing, tariffs, intellectual property, investment, capital, labor, anti-fraud, anti-corruption, privacy and data protection), as well as U.S. laws regulating U.S.-based businesses operating outside the United States, such as the Foreign Corrupt Practices Act (FCPA).
• South American Operations Exit: The ongoing disposition of South American operations carries risks related to closing conditions and potential losses.

Innovation & Technology Leadership

Research & Development Focus: Core Technology Areas:

• Data and Analytics: Leverages distinctive capabilities in data and analytics to serve various stakeholders with innovative products and end-to-end offerings.
• Artificial Intelligence (AI): Anticipates that fast-evolving AI technologies, including generative AI, will play an increasingly important role in its information systems and customer-facing technology products to improve customer experience and optimize clinical and administrative processes.
• Digital Health Technologies: Develops and utilizes advanced, on-demand digital health technologies such as telehealth and remote patient monitoring.
• Care Delivery Models: Focuses on innovating and integrating care delivery models, including in-clinic, in-home, behavioral, and virtual care.

Innovation Pipeline:

• UnitedHealth Group Incorporated maintains an ongoing commitment to significant development and operational resources to protect and enhance existing systems and develop new systems. This is aimed at keeping pace with changes in information processing technology, regulatory standards, and evolving customer preferences.
• The Company focuses on developing and delivering innovative and potentially disruptive products and services to meet evolving market demands.

Intellectual Property Portfolio:

• Patent Strategy: Holds a portfolio of patents and has patent applications pending. The Company is not substantially dependent on any single patent or group of related patents.
• Trademark Strategy: Has obtained trademark registration for the UnitedHealth Group, Optum, and UnitedHealthcare names and logos, and owns registrations for other trademarks in the United States and abroad.
• Protection Strategy: Relies on agreements with customers, confidentiality agreements with employees and third parties, and its trademarks, trade secrets, copyrights, and patents to protect its proprietary rights.

Technology Partnerships:

• Optum Insight's products are supported and distributed through an array of alliances and business partnerships with other technology vendors who integrate and interface Optum Insight’s products with their applications.

Leadership & Governance

Executive Leadership Team (as of March 2, 2026)

Leadership Continuity: The Board of Directors elects executive officers annually. UnitedHealth Group Incorporated has development and succession plans in place for its key employees and executives.

Board Composition: The Board of Directors has delegated to the Audit and Finance Committee primary responsibility for overseeing the Company’s risk management and compliance programs related to cybersecurity, data protection, and privacy. The Audit and Finance Committee receives regular updates from the Chief Security Officer and Chief Digital and Technology Officer.

Human Capital Strategy

Workforce Composition:

• Total Employees: More than 390,000 as of December 31, 2025.
• Skill Mix: Nearly 165,000 clinical professionals as of December 31, 2025.

Talent Management: Acquisition & Retention:

• Hiring Strategy: Attracts individuals aligned with its mission to help people live healthier lives and improve the health system, guided by cultural values of integrity, compassion, inclusion, relationships, innovation, and performance.
• Employee Value Proposition: Prioritizes equal pay through objective and regular evaluation of compensation practices based on performance, experience, and other relevant measures.

Diversity & Development:

• Diversity Metrics: Seeks to maintain an inclusive environment that values diverse talents, backgrounds, experiences, and perspectives. Promotes an inclusive culture and sense of belonging across talent acquisition, talent management, leadership development, careers, learning, and skills.

Environmental & Social Impact

Social Impact Initiatives:

• Community Investment: UnitedHealth Group Incorporated made an advance funding of the United Health Foundation of $250 million in the fourth quarter of 2025 as part of its restructuring and other actions.
• Product Impact: The Company's core mission to help people live healthier lives and make the health system work better for everyone implies a broad social benefit through improved access, affordability, outcomes, and experiences in health care.

Business Cyclicality & Seasonality

Demand Patterns:

• Seasonal Trends: The Inflation Reduction Act (IRA) has altered the Medicare Part D model and benefits, leading to a more consistent relationship between medical costs and premiums throughout the year, rather than previous quarterly fluctuations.
• Economic Sensitivity: Unfavorable economic conditions can impact the demand for UnitedHealth Group Incorporated's products and services, influence employer-sponsored health care offerings, and potentially lead to reduced government program funding.
• Industry Cycles: The health care market is subject to continuous change driven by demographic shifts, new regulations, political forces, and evolving payer and patient expectations.

Planning & Forecasting: UnitedHealth Group Incorporated's pricing strategy for health care benefits, products, and services is based on expected future costs, including medical care patterns, the mix and health status of people served, inflation, and labor market dynamics. The Company continuously evaluates and adjusts its approach in local markets, considering product positioning, price competitiveness, and environmental, competitive, legislative, and regulatory factors.

Regulatory Environment & Compliance

Regulatory Framework: Industry-Specific Regulations:

• Comprehensive Regulation: UnitedHealth Group Incorporated's businesses are subject to comprehensive U.S. federal and state, as well as international, laws and regulations. These include oversight from CMS, state insurance and HMO licensing bodies, and various other government agencies.
• Medicare & Medicaid: UnitedHealthcare businesses and certain Optum businesses are regulated by CMS, covering payment regulations, quality of care audits, medical loss ratio (MLR) audits, and risk adjustment data audits. UnitedHealthcare Community & State is subject to federal regulations for Medicaid and Children’s Health Insurance Programs (CHIP) contracts.
• Pharmacy Benefit Management (PBM) Regulations: Optum Rx faces federal and state regulations specific to PBM activities, including those related to rebates, formularies, utilization management, pricing benchmarks, network access, and pharmacy reimbursement. Its pharmacies must be licensed and registered with authorities such as the U.S. Drug Enforcement Administration (DEA).
• Banking Regulation: Optum Bank is supervised and regulated by the Utah State Department of Financial Institutions, the Federal Deposit Insurance Corporation (FDIC), and the Consumer Financial Protection Bureau.
• Corporate Practice of Medicine/Fee-Splitting: Certain businesses functioning as direct medical service providers are subject to state laws prohibiting specific entities from practicing medicine or employing physicians, or engaging in fee-splitting.

Trade & Export Controls:

• Non-U.S. Operations: International businesses are subject to U.S. laws regulating U.S.-based businesses operating outside the United States, such as the Foreign Corrupt Practices Act (FCPA), and various non-U.S. regulatory regimes.

Legal Proceedings:

• Routine Legal Actions: UnitedHealth Group Incorporated is routinely party to a variety of legal actions and regulatory inquiries, including class actions and suits brought by members, care providers, consumer advocacy organizations, customers, shareholders, and regulators. These matters include medical malpractice, employment, intellectual property, antitrust, privacy, and contract claims, as well as claims related to health care benefits coverage and other business practices.
• Government Investigations: The Company is subject to routine, regular, and special governmental investigations, audits, reviews, and assessments by various federal and state agencies (e.g., CMS, Office of Inspector General (OIG), U.S. Department of Justice (DOJ), SEC, Internal Revenue Service (IRS)). Risk adjustment data validation (RADV) audits are performed by CMS.
• False Claims Act Lawsuit: An ongoing lawsuit, initially filed by a whistleblower in 2011, alleges improper risk adjustment submissions and violations of the False Claims Act. In March 2025, a Special Master recommended summary judgment in the Company's favor, but the DOJ filed a motion to reject this report in April 2025.

Tax Strategy & Considerations

Tax Profile (2025):

• Effective Tax Rate: 12.9% (down from 24.1% in 2024).
• Geographic Tax Planning: Undistributed earnings from non-U.S. subsidiaries are intended to be indefinitely reinvested in non-U.S. operations, resulting in minimal U.S. deferred taxes recorded.
• Taxes Paid: Total taxes paid were $8.2 billion in 2025, with 73% domestic and 27% foreign (primarily to Ireland).
• Unrecognized Tax Benefits: As of December 31, 2025, there were $2.8 billion of unrecognized tax benefits which, if recognized, would affect the effective tax rate.
• Tax Audits: U.S. Internal Revenue Service (IRS) exams are completed for fiscal years 2016 and prior. The 2017 through 2023 tax years are currently under exam by the IRS. The Company is subject to examination in non-U.S. jurisdictions for years 2015 and forward.

Insurance & Risk Transfer

Risk Management Framework:

• Insurance Coverage: UnitedHealth Group Incorporated is largely self-insured for legal actions, including medical malpractice claims. While external insurers are engaged for some matters, coverage may be disputed or insufficient.
• Risk Transfer Mechanisms: The Company has entered into various agreements with reinsurers that could limit its risk of loss under certain circumstances, thereby reducing its capital and surplus requirements. These agreements are accounted for under deposit accounting.
• Cybersecurity Program: The Company assesses its cybersecurity and data protection initiatives through the National Institute of Standards and Technology (NIST) Cybersecurity Framework. This includes processes for risk assessment, incident management and response, third-party risk management, and continuous auditing and improvement.